Zealand Pharma to seek FDA approval of its treatment for rare genetic disorder in babies

Norge Nyheter Nyheter

Zealand Pharma to seek FDA approval of its treatment for rare genetic disorder in babies
Norge Siste Nytt,Norge Overskrifter
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

U.S.-listed shares of Zealand Pharma undefinedundefined soared 21.2% in premarket trading on Thursday after the company said a Phase 3 clinical trial...

U.S.-listed shares of Zealand Pharma soared 21.2% in premarket trading on Thursday after the company said a Phase 3 clinical trial evaluating its investigational treatment for babies with a rare genetic disorder met the primary endpoint. Zealand is testing dasiglucagon as a treatment for pediatric patients with congenital hyperinsulinism, which causes excess insulin secretion and low blood sugar.

2% in premarket trading on Thursday after the company said a Phase 3 clinical trial evaluating its investigational treatment for babies with a rare genetic disorder met the primary endpoint. Zealand is testing dasiglucagon as a treatment for pediatric patients with congenital hyperinsulinism, which causes excess insulin secretion and low blood sugar.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

MarketWatch /  🏆 3. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

‘Pharma Bro’ Martin Shkreli Out of Jail—and Back on Facebook‘Pharma Bro’ Martin Shkreli Out of Jail—and Back on FacebookOne of the first things “Pharma bro” Martin Shkreli did when he was released early from federal lockup for transfer to a halfway house was make a joke about it... on Facebook.
Les mer »

'Pharma Bro' Shkreli freed from prison for halfway house'Pharma Bro' Shkreli freed from prison for halfway houseConvicted pharmaceutical executive Martin Shkreli was freed Wednesday from prison after serving much of a seven-year prison sentence for lying to hedge fund investors and cheating investors in a drug company. The move was confirmed by the Federal Bureau of Prisons. “I am pleased to report that Martin Shkreli has been released from Allenwood prison and transferred to a BOP halfway house after completing all programs that allowed for his prison sentence to be shortened,” Brafman said.
Les mer »

'Pharma Bro' Shkreli freed from prison for halfway house'Pharma Bro' Shkreli freed from prison for halfway houseNEW YORK (AP) — Convicted pharmaceutical executive Martin Shkreli was freed Wednesday from prison after serving much of a seven-year prison sentence for lying to hedge fund investors and cheating investors in a drug company.
Les mer »

'Pharma Bro' Martin Shkreli freed from prison for halfway house'Pharma Bro' Martin Shkreli freed from prison for halfway houseMartin Shkreli was transferred to a Bureau of Prisons halfway house after completing programs that enabled him to earn early release, according to his lawyer.
Les mer »

Martin Shkreli, Wall Street's 'Pharma bro,' is out of prison earlyMartin Shkreli, Wall Street's 'Pharma bro,' is out of prison earlyShkreli had been serving a seven-year sentence on federal charges of wire and securities fraud.
Les mer »



Render Time: 2025-03-24 17:48:27